MedTrace Logo

High Density Lipoprotein Subspecies and Coronary Disease

NCT00005676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2700

Last updated 2014-03-04

No results posted yet for this study

Summary

To investigate the relative contributions of high density lipoprotein-C (HDL-C) subspecies to risk for coronary heart disease (CHD) in two distinct existing populations (samples from the VA-HIT study and the Framingham Offspring Study \[FOS\]) as well as the response of these subfractions to gemfibrozil treatment.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Tufts University

    lead OTHER

Principal Investigators

  • Bela Asztalos, PhD · Tufts University

Eligibility

Min Age
41 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-04-30
Primary Completion
2005-08-31
Completion
2005-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005676 on ClinicalTrials.gov